Patents by Inventor Herbert Meltzer

Herbert Meltzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF ADMINISTRATION OF NMDA RECEPTOR AGONISTS
    Publication number: 20190351006
    Abstract: Disclosed are methods for treating a cognitive or neurological diseases and disorders comprising the step of administering rapastinel or a pharmaceutically acceptable salt, ester or metabolite thereof to a patient in need thereof, wherein rapastinel is administered for an administration period of about one to about fourteen days followed by a holiday period of at least about one to sixteen weeks wherein rapastinel is not administered.
    Type: Application
    Filed: November 9, 2018
    Publication date: November 21, 2019
    Inventors: Pradeep Banerjee, Herbert Meltzer
  • Screening method for controlling agranulocytosis
    Patent number: 5300422
    Abstract: A screening method for detecting the vulnerability of patients on clozapine therapy to developing agranulocytosis which comprises establishing the concentration of N-desmethylclozapine in the blood or bone marrow of said patient. In addition, a method of determining patient sensitivity to N-desmethylclozapine is provided which comprises collecting heparinized blood and assaying it for stem cell sensitivity to N-desmethylclozapine.
    Type: Grant
    Filed: December 4, 1991
    Date of Patent: April 5, 1994
    Assignee: Case Western Reserve University
    Inventors: Stanton L. Gerson, Herbert Meltzer